Quick Answer
AGIOS PHARMACEUTICALS, INC. reported Net Income of -$412.78 million for fiscal year 2025.
AGIOS PHARMACEUTICALS, INC. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$412.78M | -161.3% |
| 2024 | $673.73M | +291.4% |
| 2023 | -$352.09M | -51.9% |
| 2022 | -$231.80M | -114.4% |
| 2021 | $1.60B | +590.2% |
| 2020 | -$327.37M | +20.4% |
| 2019 | -$411.47M | -18.9% |
| 2018 | -$346.03M | -10.0% |
| 2017 | -$314.67M | -58.5% |
| 2016 | -$198.47M | -68.6% |
| 2015 | -$117.73M | -120.0% |
| 2014 | -$53.50M | -35.8% |
| 2013 | -$39.41M | -96.0% |
| 2012 | -$20.10M | +15.2% |
| 2011 | -$23.71M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$103.43M | -110.9% | +7.7% |
| June 30, 2025 | -$112.02M | -16.5% | -25.5% |
| March 31, 2025 | -$89.29M | -9.5% | -109.4% |
| September 30, 2024 | $947.91M | +1138.0% | +1086.2% |
| June 30, 2024 | -$96.12M | -14.7% | -17.9% |
| March 31, 2024 | -$81.55M | -0.7% | +10.7% |
| September 30, 2023 | -$91.32M | -11.7% | -9.0% |
| June 30, 2023 | -$83.81M | +8.7% | -3.4% |
- AGIOS PHARMACEUTICALS, INC. showed a decrease of -161.3% in Net Income compared to the prior fiscal year.
- Over the 2011–2025 period, AGIOS PHARMACEUTICALS, INC.’s net income has declined by 1641.3% (from -$23.71 million to -$412.78 million).
- The most recent figure is from AGIOS PHARMACEUTICALS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: